Citius Oncology (NASDAQ:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals (NASDAQ:CTXR), has entered into a distribution services agreement with Cardinal Health (NYSE:CAH).
This agreement is designed to help provide access to LYMPHIR (denileukin diftitox-cxdl), an innovative immunotherapy FDA-approved for the treatment of adults
Australia’s ANZ, one of the country’s “big four” banks, has agreed to pay a record fine of $240 million Australian...
Israel's tallest residential tower will be built in the heart of Ramat Gan's Diamond Exchange district. Ramat Ran Municipality...
After nearly a year of time correction and muted returns, Kotak Mutual Fund’s Atul Bhole believes the stock market’s risk-reward...
The dollar held steady on Monday ahead of a pivotal week filled with central bank decisions led by the Federal...
President Donald Trump on Sunday said foreign workers sent to the United States are “welcome” and he doesn’t want to...
By Casey Hall SHANGHAI (Reuters) -China's leaders have pledged to put an end to aggressive price cuts by some Chinese...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
